Prime Medicine (PRME) Leases (2021 - 2025)
Historic Leases for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $117.9 million.
- Prime Medicine's Leases rose 13877.52% to $117.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.9 million, marking a year-over-year increase of 13877.52%. This contributed to the annual value of $47.2 million for FY2024, which is 23825.41% up from last year.
- Per Prime Medicine's latest filing, its Leases stood at $117.9 million for Q3 2025, which was up 13877.52% from $120.2 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Leases ranged from a high of $120.2 million in Q2 2025 and a low of $10.7 million during Q4 2021
- For the 5-year period, Prime Medicine's Leases averaged around $47.0 million, with its median value being $38.6 million (2022).
- Per our database at Business Quant, Prime Medicine's Leases crashed by 5281.44% in 2023 and then surged by 23825.41% in 2024.
- Prime Medicine's Leases (Quarter) stood at $10.7 million in 2021, then surged by 174.94% to $29.5 million in 2022, then crashed by 52.81% to $13.9 million in 2023, then soared by 238.25% to $47.2 million in 2024, then surged by 149.96% to $117.9 million in 2025.
- Its last three reported values are $117.9 million in Q3 2025, $120.2 million for Q2 2025, and $76.8 million during Q1 2025.